Spiro Rombotis
2011
In 2011, Spiro Rombotis earned a total compensation of $685.8K as President and Chief Executive Officer at Cyclacel Pharmaceuticals, a 4% increase compared to previous year.
Compensation breakdown
| Bonus | $100,000 |
|---|---|
| Salary | $490,383 |
| Stock Awards | $62,250 |
| Other | $33,131 |
| Total | $685,764 |
Rombotis received $490.4K in salary, accounting for 72% of the total pay in 2011.
Rombotis also received $100K in bonus, $62.3K in stock awards and $33.1K in other compensation.
Rankings
In 2011, Spiro Rombotis' compensation ranked 7,004th out of 10,747 executives tracked by ExecPay. In other words, Rombotis earned more than 34.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,004 out of 10,747 | 35th |
Division Manufacturing | 2,552 out of 3,960 | 36th |
Major group Chemicals And Allied Products | 611 out of 1,033 | 41st |
Industry group Drugs | 414 out of 781 | 47th |
Industry Pharmaceutical Preparations | 324 out of 571 | 43rd |
Source: SEC filing on April 3, 2013.
Rombotis' colleagues
We found two more compensation records of executives who worked with Spiro Rombotis at Cyclacel Pharmaceuticals in 2011.
News
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2023 pay slips 13% to $661K
May 7, 2024
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2022 pay falls 43% to $764K
April 28, 2023
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2021 pay slips 5% to $1.3M
April 26, 2022
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2020 pay jumps 39% to $1.4M
April 29, 2021
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2019 pay jumps 35% to $1M
May 12, 2020